Cancer Family
Solid Neoplasm
CI-CAN-00000052Explore in graph →
Non-malignant1,823 active trials28 evidence items
- NCIt
- C9292
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000052Explore in graph →
Clinical trials
6,089 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00039390 | Gefitinib and Capecitabine in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 41 | National Cancer Institute (NCI)NIH | 1 | Jan 25, 2013 | clinicaltrials |
| NCT00079352 | Flavopiridol, Gemcitabine, and Irinotecan in Treating Patients With Unresectable or Metastatic Solid Tumors | completed | Phase 1 | 24 | National Cancer Institute (NCI)NIH | 1 | Jan 25, 2013 | clinicaltrials |
| NCT00087217 | 17-N-Allylamino-17-Demethoxygeldanamycin and Paclitaxel in Treating Patients With Metastatic or Unresectable Solid Tumor | completed | Phase 1 | 35 | National Cancer Institute (NCI)NIH | 1 | Jan 25, 2013 | clinicaltrials |
| NCT00089271 | 17-DMAG in Treating Patients With Metastatic or Unresectable Solid Tumors or Lymphomas | completed | Phase 1 | 60 | National Cancer Institute (NCI)NIH | 1 | Jan 25, 2013 | clinicaltrials |
| NCT00003970 | Genetic Testing Plus Irinotecan in Treating Patients With Solid Tumors or Lymphoma | completed | Phase 1 | 60 | National Cancer Institute (NCI)NIH | 1 | Jan 24, 2013 | clinicaltrials |
| NCT00042809 | Erlotinib, Trastuzumab, and Paclitaxel in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 40 | National Cancer Institute (NCI)NIH | 1 | Jan 24, 2013 | clinicaltrials |
| NCT00062127 | Irinotecan and Thalidomide in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 35 | National Cancer Institute (NCI)NIH | 1 | Jan 24, 2013 | clinicaltrials |
| NCT00074022 | GTI-2040 and Docetaxel in Treating Patients With Recurrent, Metastatic, or Unresectable Locally Advanced Non-Small Cell Lung Cancer, Prostate Cancer, or Other Solid Tumors | completed | Phase 1 / Phase 2 | 48 | National Cancer Institute (NCI)NIH | 1 | Jan 24, 2013 | clinicaltrials |
| NCT00077155 | Cilengitide (EMD 121974) in Treating Patients With Advanced Solid Tumors or Lymphoma | completed | Phase 1 | 45 | National Cancer Institute (NCI)NIH | 1 | Jan 24, 2013 | clinicaltrials |
| NCT00078962 | GTI-2040 and Gemcitabine in Treating Patients With Metastatic or Unresectable Solid Tumors | completed | Phase 1 | 40 | National Cancer Institute (NCI)NIH | 1 | Jan 24, 2013 | clinicaltrials |
| NCT00098891 | MS-275 and Isotretinoin in Treating Patients With Metastatic or Advanced Solid Tumors or Lymphomas | completed | Phase 1 | 24 | National Cancer Institute (NCI)NIH | 1 | Jan 24, 2013 | clinicaltrials |
| NCT00005973 | BMS-214662 in Treating Patients With Solid Tumors | completed | Phase 1 | 36 | National Cancer Institute (NCI)NIH | 1 | Jan 23, 2013 | clinicaltrials |
| NCT00024206 | SU6668 in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 12 | National Cancer Institute (NCI)NIH | 1 | Jan 23, 2013 | clinicaltrials |
| NCT00040781 | Gefitinib in Treating Children With Refractory Solid Tumors | completed | Phase 1 | 45 | National Cancer Institute (NCI)NIH | 1 | Jan 23, 2013 | clinicaltrials |
| NCT00798889 | Rollover Protocol for Prior SU011248 Protocols | completed | N/A | 314 | PfizerINDUSTRY | 11 | Jan 21, 2013 | clinicaltrials |
| NCT00005805 | St. John's Wort in Relieving Fatigue in Patients Undergoing Chemotherapy or Hormone Therapy for Cancer | completed | Phase 3 | — | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jan 18, 2013 | clinicaltrials |
| NCT00039481 | Oblimersen Plus Combination Chemotherapy and Dexrazoxane in Treating Children and Adolescents With Relapsed or Refractory Solid Tumors | completed | Phase 1 | 15 | National Cancer Institute (NCI)NIH | 1 | Jan 17, 2013 | clinicaltrials |
| NCT00084786 | Gefitinib and Docetaxel in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | — | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jan 17, 2013 | clinicaltrials |
| NCT00003282 | EF5 in Treating Patients With Solid Tumors | completed | Phase 1 | 50 | National Cancer Institute (NCI)NIH | 1 | Jan 16, 2013 | clinicaltrials |
| NCT00028587 | PS-341 and Combination Chemotherapy in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 96 | National Cancer Institute (NCI)NIH | 1 | Jan 16, 2013 | clinicaltrials |
| NCT00028821 | 2-Methoxyestradiol in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 60 | National Cancer Institute (NCI)NIH | 1 | Jan 16, 2013 | clinicaltrials |
| NCT00030498 | Erlotinib in Treating Patients With Solid Tumors and Liver or Kidney Dysfunction | completed | Phase 1 | 75 | National Cancer Institute (NCI)NIH | 1 | Jan 16, 2013 | clinicaltrials |
| NCT00053963 | FR901228 in Treating Children With Refractory or Recurrent Solid Tumors or Leukemia | completed | Phase 1 | 30 | National Cancer Institute (NCI)NIH | 1 | Jan 16, 2013 | clinicaltrials |
| NCT00363272 | Ispinesib in Treating Young Patients With Relapsed or Refractory Solid Tumors or Lymphoma | completed | Phase 1 | 30 | National Cancer Institute (NCI)NIH | 1 | Jan 16, 2013 | clinicaltrials |
| NCT01472003 | An Evaluation of the Biodistribution and Imaging Characteristics of ABT-806i (111In-ABT-806) in Subjects With Advanced Solid Tumor Types | completed | Phase 1 | 18 | AbbVie (prior sponsor, Abbott)INDUSTRY | 1 | Jan 14, 2013 | clinicaltrials |
| NCT00017238 | KRN5500 in Treating Patients With Solid Tumors | completed | Phase 1 | 40 | National Cancer Institute (NCI)NIH | 1 | Jan 11, 2013 | clinicaltrials |
| NCT00026169 | Imatinib Mesylate in Treating Patients With Advanced Cancer and Kidney Failure | completed | Phase 1 | 69 | National Cancer Institute (NCI)NIH | 1 | Jan 10, 2013 | clinicaltrials |
| NCT00601133 | Function and Balance for Inpatient Rehabilitation | completed | — | 24 | M.D. Anderson Cancer CenterOTHER | 1 | Jan 10, 2013 | clinicaltrials |
| NCT00891072 | Gossypol, Paclitaxel, and Carboplatin in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery | completed | Phase 1 | 36 | National Cancer Institute (NCI)NIH | 1 | Jan 10, 2013 | clinicaltrials |
| NCT00047034 | E7389 in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 31 | National Cancer Institute (NCI)NIH | 1 | Jan 7, 2013 | clinicaltrials |
| NCT00118170 | Sorafenib in Treating Patients With Metastatic or Unresectable Solid Tumors, Multiple Myeloma, or Non-Hodgkin's Lymphoma With or Without Impaired Liver or Kidney Function | completed | Phase 1 | 150 | National Cancer Institute (NCI)NIH | 1 | Jan 7, 2013 | clinicaltrials |
| NCT00124605 | Arsenic Trioxide and Pamidronate in Treating Patients With Advanced Solid Tumors or Multiple Myeloma | completed | Phase 1 | 24 | National Cancer Institute (NCI)NIH | 1 | Jan 7, 2013 | clinicaltrials |
| NCT01380249 | PDM08 Clinical Trial in Advanced Solid Tumors | completed | Phase 1 | 22 | Prodimed S.A.OTHER | 1 | Jan 7, 2013 | clinicaltrials |
| NCT00849550 | Safety and Dosage Study of RAD001 (Everolimus) in Combination With Current Standard of Care to Treat Advanced Solid Tumors.(COBRA) | completed | Phase 1 | 32 | Herbert HurwitzOTHER | 1 | Dec 24, 2012 | clinicaltrials |
| NCT01055795 | Safety Study of Bevacizumab, Everolimus and LBH589 (BEL) for Advanced Solid Tumors(BEL) | completed | Phase 1 | 14 | Herbert HurwitzOTHER | 1 | Dec 24, 2012 | clinicaltrials |
| NCT01755390 | A Dose Finding Study of XRP6258 in Patients With Advanced Solid Tumors | completed | Phase 1 | 42 | SanofiINDUSTRY | 2 | Dec 24, 2012 | clinicaltrials |
| NCT01336582 | Pharmacokinetic Study of SYP-0704A and Taxotere to Treat Patient With Advanced Solid Cancer | completed | Phase 1 | 42 | Samyang Biopharmaceuticals CorporationINDUSTRY | 1 | Dec 21, 2012 | clinicaltrials |
| NCT00098969 | UMCC 2003-064 Resveratrol in Preventing Cancer in Healthy Participants(IRB 2004-535) | completed | Phase 1 | 40 | National Cancer Institute (NCI)NIH | 2 | Dec 17, 2012 | clinicaltrials |
| NCT01748019 | ST1968 Intravenous (Weekly) in Solid Tumors | completed | Phase 1 | 62 | sigma-tau i.f.r. S.p.A.INDUSTRY | 0 | Dec 12, 2012 | clinicaltrials |
| NCT00349167 | PR-104 in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 27 | Proacta, IncorporatedINDUSTRY | 1 | Nov 30, 2012 | clinicaltrials |
| NCT00551005 | Etoposide and Celecoxib in Patients With Advanced Cancer | completed | Phase 1 | 58 | City of Hope Medical CenterOTHER | 0 | Nov 22, 2012 | clinicaltrials |
| NCT00840190 | A Study Of Selective Cyclin Dependent Kinase Inhibitor P1446A-05 In Subjects With Advanced Refractory Malignancies(Serenity) | completed | Phase 1 | 29 | Piramal Enterprises LimitedINDUSTRY | 1 | Nov 21, 2012 | clinicaltrials |
| NCT00128622 | Denileukin Diftitox Followed by Vaccine Therapy in Treating Patients With Metastatic Cancer | completed | Phase 1 | 24 | H. Kim LyerlyOTHER | 1 | Nov 12, 2012 | clinicaltrials |
| NCT00551889 | Cyclophosphamide and Celecoxib in Treating Patients With Advanced Cancer | completed | Phase 1 | 57 | City of Hope Medical CenterOTHER | 0 | Nov 12, 2012 | clinicaltrials |
| NCT00003132 | Bryostatin 1 Plus Cisplatin in Treating Patients With Metastatic or Unresectable Cancer | completed | Phase 1 | — | NYU Langone HealthOTHER | 1 | Nov 9, 2012 | clinicaltrials |
| NCT00004002 | PS-341 in Treating Patients With Advanced Solid Tumors or Lymphoma | completed | Phase 1 | — | NYU Langone HealthOTHER | 1 | Nov 9, 2012 | clinicaltrials |
| NCT00005990 | R115777 Plus Topotecan in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | — | NYU Langone HealthOTHER | 1 | Nov 9, 2012 | clinicaltrials |
| NCT00003021 | Bizelesin in Treating Patients With Advanced Cancer | completed | Phase 1 | — | The University of Texas Health Science Center at San AntonioOTHER | 1 | Nov 6, 2012 | clinicaltrials |
| NCT00697502 | Study of Capecitabine In Patients With Solid Tumors | completed | Phase 1 | 23 | National University Hospital, SingaporeOTHER | 1 | Nov 1, 2012 | clinicaltrials |
| NCT00808184 | Pharmacokinetic Study of CPT-11, Raltegravir and Midazolam With Characterisation of UGT1A1 Genotype | completed | Phase 4 | 25 | National University Hospital, SingaporeOTHER | 1 | Nov 1, 2012 | clinicaltrials |
Data updated 23 days agoSource updated Jan 25, 2013source: clinicaltrials